High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. - Wikidata - awgldk - TriplyDB

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.

http://www.wikidata.org/entity/Q34539604

about

Stem cell transplantation for neuroblastoma Neuroblastoma: issues in transplantation Activating mutations in ALK provide a therapeutic target in neuroblastoma.Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005).Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma.Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma.High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis.The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma.Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures.ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.Plasticity and maintenance of hematopoietic stem cells during development.Advances in Risk Classification and Treatment Strategies for Neuroblastoma.Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma.Primary intrathoracic malignant neurogenic tumor: report of three cases and comparison with benign neurogenic tumors resected at our institution.Hematologic recovery after tandem high-dose chemotherapy and autologous stem cell transplantation in children with high-risk solid tumors.Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1 Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas Management and outcome of stage 3 neuroblastoma.Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.Retrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastoma Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features.High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma.Optimal time to start peripheral blood stem cell collection in children with high-risk solid tumors.

P2860

Q24629221-B6B02EBD-270A-4860-83E0-AD030489536A Q27008197-DF0B7714-7546-4801-B84C-2F80C882080E Q27851452-E9FA68A3-527B-43E8-9F09-40E0E38AB95F Q28474594-0E129A8D-6A20-43F7-B409-0FC68BA25C9F Q30657233-F2FD3805-9A51-46F9-B62F-972CC84CD5AF Q33349703-39FCFA9B-6AC4-4933-8C14-6DE286FC6B5B Q33691441-F0E0B05C-D90E-4956-922D-2C014432EDB4 Q33730375-2F7DABD3-7256-40AB-B485-B5008A27A9DE Q33807214-801B67CC-FA58-43B0-99ED-43A5A9ED3E9D Q33908476-CF5DDD68-23D7-44F7-A961-87B891E37496 Q33916362-26081B86-3D9F-430A-B413-482C0CF6D843 Q33924534-68F0A227-CA5D-4F76-AD8B-7CD0A67C80D8 Q34200900-4B3F375B-D781-4CDC-999C-F13E39160389 Q34351080-14921245-ED6A-497B-9813-77B72F4E2AB6 Q34549193-D1A9064F-CE96-4666-BE43-92DB515FFB6C Q34660375-BC002D34-31A0-4003-AAC1-4F503D2C3152 Q34667915-86F44B95-35BF-4F03-9CB9-0BE7BD5FD668 Q34703990-1B68AC15-F085-4E31-8CE5-54C78AF037E2 Q34785880-4F17BF41-BABF-45EF-9A4E-BFFE8288AFD7 Q34891827-6D65C336-7440-4121-9138-E217727FF2FF Q35077703-AD1CD157-4525-4543-A053-1DE41DB0071A Q35798960-FA4A90FB-50B8-4325-ABA5-0A9C004EF746 Q35804722-70A80A86-3632-4603-946A-56FBDEFED805 Q36053801-733C03F1-D821-4A76-9482-63907CC7A6B9 Q36212437-294C30E7-C821-4849-B175-64759DE4DD72 Q36411061-073086BA-2308-4C79-8CDD-8F59180099C2 Q36564034-09377B77-3A5C-422C-BD28-ABE1A41C1543 Q36589477-C3E9EB51-F023-45A1-989E-C732C7BAEA0C Q36782374-AB9B494F-6677-4B88-80EA-EB9F3E6A2844 Q36800194-3A1566DD-DC6B-4B73-8781-642D94B01D44 Q36867863-F03CA0C2-CE44-4B68-B7BF-876A1594CEFA Q36910335-37D423FA-4831-4387-BDDA-4761EEC3EECD Q36989758-69892A57-C0C1-4471-9250-A990D0B14897 Q37056086-36FB0AE9-3ACB-4D42-8A1E-14E4224283C6 Q37144023-78B1A062-6CBE-4CD5-9621-B9454904F0EC Q37222520-7048EAC1-1974-45C6-8E61-968729FD840B Q37232057-68946063-9065-48AE-87F0-152E451CFA37 Q37284671-560D5C4E-30FF-424C-8780-AB81B1494867 Q37451551-A8D6A711-1702-491B-8AD8-C230E00D928B Q37473582-1F40E111-1C35-46AB-94CE-A7CAC47AC5D5

P2860

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.

http://www.wikidata.org/entity/Q34539604

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

High-risk neuroblastoma treate ...... on: long-term survival update.

@ast

High-risk neuroblastoma treate ...... on: long-term survival update.

@en

High-risk neuroblastoma treate ...... on: long-term survival update.

@nl

type

label

High-risk neuroblastoma treate ...... on: long-term survival update.

@ast

High-risk neuroblastoma treate ...... on: long-term survival update.

@en

High-risk neuroblastoma treate ...... on: long-term survival update.

@nl

prefLabel

High-risk neuroblastoma treate ...... on: long-term survival update.

@ast

High-risk neuroblastoma treate ...... on: long-term survival update.

@en

High-risk neuroblastoma treate ...... on: long-term survival update.

@nl

P1433

Q34539604-9F7AAA3A-A454-4F8F-95AE-F7B825B811F1

P1476

Q34539604-D4A8A6F0-2618-46E6-AB23-5B68B4BABB67

P2093

Q34539604-0043AE84-EE59-4FEA-A6D0-7D1AF5B3339F

Q34539604-4E3E778B-4DD2-4437-A2DD-9A5034E02B19

Q34539604-5377D029-990B-4620-8BF3-15B56E842DA2

Q34539604-7CBBFD87-A990-4E34-9F59-1F5FBB836CF0

Q34539604-7E46E838-AED7-4C43-A4D4-DFFDDF296159

Q34539604-AB1B71BF-B157-4576-A17A-DC67174A8D3C

Q34539604-D936C207-F733-4E21-9923-226655AC58DD

Q34539604-EA451232-995C-477E-90DB-F20ABE84F571

Q34539604-FE9EC5E8-4B7F-4EA4-B754-6639BCFE93C1

P304

Q34539604-7EEB199C-19EB-46C4-B90D-A0191551ABC5

P31

Q34539604-902728E5-4EE6-4B37-9044-31F1E6262287

P356

Q34539604-665FC0C8-7296-4A82-9831-A2A96196C860

P407

Q34539604-C96C0E0E-B1E2-407C-AEEE-78A0724726CF

P433

Q34539604-69E2D784-E4BE-4EB5-B4B6-7FDED80F85AF

P478

Q34539604-732BF2DD-4AF4-4D42-8665-7E78E775A27C

P577

Q34539604-6AE79830-6A15-4289-AEEF-226C2C8AD8FE

P698

Q34539604-7E97AF5F-CDFB-4579-BF03-A363273BDDFE

P356

JCO.2006.05.6986

P1433

Journal of Clinical Oncology

P1476

High-risk neuroblastoma treate ...... on: long-term survival update.

@en

P2093

Cheryl Medeiros-Nancarrow

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Karen Marcus

http://www.w3.org/2001/XMLSchema#string

Lisa Diller

http://www.w3.org/2001/XMLSchema#string

Michael Pulsipher

http://www.w3.org/2001/XMLSchema#string

Rani E George

http://www.w3.org/2001/XMLSchema#string

Robert C Shamberger

http://www.w3.org/2001/XMLSchema#string

Shuli Li

http://www.w3.org/2001/XMLSchema#string

Stephan A Grupp

http://www.w3.org/2001/XMLSchema#string

P304

2891-2896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2006.05.6986

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16782928

http://www.w3.org/2001/XMLSchema#string